Skip to main content
TRVI logo

TRVI · Trevi Therapeutics, Inc. · Analyst Estimates

Track TRVI — free
$13.49 -0.23 (-1.68%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.96B
Shares
142.56M
Volume · Nov 20 1.37M Avg daily vol (3M) 1.97M

Analyst Estimates

Compare analyst forecasts for Trevi Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-20 15:00 UTC · Publication dates shown per estimate · 4 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.55
-0.49
-0.38
9
-0.48
-0.48
-0.48
-0.48
7
7
— —
Revenue
USD
Publication date not stated
0.00
0.00
0.00
10
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.81
-0.61
-0.39
10
-0.58
-0.58
-0.58
-0.58
5
5
1
1
Revenue
USD
Publication date not stated
0.00
0.00
0.00
10
— — — — — — — —
Key facts CIK 1563880 CUSIP 89532M101 13F (30d) 230 filings 216 filers Visit website Investor relations